Scientists are planning to infect British volunteers with a weakened, computer-designed form of the coronavirus, which researchers believe could work as a vaccine.
The early-stage trial will take place in a special 24-bed quarantine clinic in Whitechapel, east London. The US biotech company behind it, Codagenix, is in talks with UK regulators and expects to begin before the end of the year.
The vaccine consists of an enfeebled version of the coronavirus, designed using special software and built in a laboratory. The aim is produce a cheap inoculation that would be administered as a nose drop.
Link here to view the full Times article.